Indications and uses
Indication and Usage: In the last step of skin care, spread and tap it softly on the whole face.
Indication and Usage: In the last step of skin care, spread and tap it softly on the whole face.
Dosage and Administration: For your face, use it about same amout as a size of been(about 1.5mL)
Active Ingredients:
ETHYLHEXYL METHOXYCINNAMATE 5.65%, TITANIUM DIOXIDE 8,98%, ZINC OXIDE 0.7656%
Inactive Ingredients:
SNAIL SECRETION FILTRATE, CYCLOPENTASILOXANE, POLYMETHYL METHACRYLATE, PEG/PPG-17/6 COPOLYMER, DICAPRYLYL CARBONATE, DIMETHICONE, CETYL PEG/PPG-10/1 DIMETHICONE, ARBUTINE, SODIUMCHLORIDE, OZOKERITE, CYCLOPENTASILOXANE, TRIETHYL CITRATE,DISTEARDIMONIUM HECTORITE,GLYCOSYLTREHALOSE,HYDROGENATED STARCH HYDROLYSATE,CALCIUM STEARATE,HEXYL LAURATE, SORBITAN SESQUIOLEATE,SODIUM HYALURONATE,LAURYLPEG/PPG-18/18 METHICONE,SORBITAN SESQUIOLEATE,ALLANTOIN,PANTHENOL,BETA-GLUCAN,ADENOSINE,LECITHIN,TOCOPHERYL ACETATE ,CAPRYLIC/CAPRIC TRIGLYCERIDE,UBIQUINONE ,DIISOPROPYL ADIPATE,GLYCERIN,ARNICA MONTANA FLOWER EXTRACT,ARTEMISIA ABSINTHIUM EXTRACT,ACHILLEA MILLEFOLIUM EXTRACT ,GENTIANA LUTEA ROOT EXTRACT ,ETHANOL,CASTANEA SATIVA(CHESTNUT) SEED EXTRACT,CARICA PAPAYA(PAPAYA) FRUIT EXTRACT,LAVANDULA ANGUSTIFOLIA(LAVENDER)EXTRACT,CORNUSOFFICINALIS FRUIT EXTRACT,CAPRYLYL GLYCOL,ETHYLHEXYLGLYCERIN,TROPOLONE,DISODIUM EDTA,FRAGRANCE,CI 77491 ,CI 77492 ,CI 77499
Purpose: UVA/UVB Protection
Warnings:
1. If following symptoms occur, stop use and consult a doctor : red spots, swelling, itcihng, irritation, or symtoms on applied skin under direct sunlight.
2. Do not use on scarred skin, or if you have dermatitis or eczema
3. Keep the cap close on its product
4. Keep away from direct sunlight or heat.
5. This product blocks UVA rays and ultraviolet protection effectiveness have been measured by the Food and Drug Administration methods and standards
Keep out of reach of children:
Keep out of reach of babies and children
Indication and Usage:
In the last step of skin care, spread and tap it softly on the whole face.
Dosage and Administration:
For your face, use it about same amout as a size of been(about 1.5mL)
| Class | Version | Type | Effective |
|---|---|---|---|
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62171-030-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-a864-f424-e053-dadaa90a57ce | 9025aecb-a806-41d5-9052-408acdb699ec |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62171-030-01 | SNAIL REPAIR BLEMISH BALM | 50 mL in 1 CARTON | CREAM | 50 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62171-030 | 62171-030-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIM |
| DIMETHICONE | 92RU3N3Y1O | IACT |
| TRIETHYL CITRATE | 8Z96QXD6UM | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 1 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, ORALLY DISINTEGRATING / ORAL | 17 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, EXTENDED RELEASE / ORAL | 160 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, DELAYED RELEASE / ORAL | 70 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 7 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, COATED PELLETS / ORAL | 147 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 100 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, EXTENDED RELEASE / ORAL | 129 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, CHEWABLE / ORAL | 34 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | GRANULE, FOR SUSPENSION / ORAL | 64 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, COATED / ORAL | 7 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET / ORAL | 52 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | SUSPENSION / ORAL | 71 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 10 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 147 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE / ORAL | 10 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, FILM COATED / ORAL | 3 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, DELAYED RELEASE / ORAL | 120 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | SUSPENSION, EXTENDED RELEASE / ORAL | 5 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3fc805e4-186d-4186-9697-f978aa8e0fff | 9025aecb-a806-41d5-9052-408acdb699ec | 2014-04-17 | Warnings | 3fc805e4-186d-4186-9697-f978aa8e0fff 9025aecb-a806-41d5-9052-408acdb699ec |
Adverse event summaries are temporarily unavailable. Other product information remains available.